Abbott Park, IL - Abbott Laboratories announced the launch of the next-generation Perclose ® suture-mediated vessel closure system, Perclose ProGlide TM, featuring a polypropylene monofilament suture.

Use of the Perclose ProGlide suture-mediated closure strategy to achieve vascular access-site hemostasis after transfemoral TAVR results in fewer major vascular complications than does deployment of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. LAS VEGAS — In a comparison of two vascular closure ...

Prior to the inception of percutaneous arterial closure devices, small-sheath size arterial puncture sites were managed with manual compression, which is labor intensive and requires a health care ...

En route to Abbott’s acquisition of St. Jude Medical, the duo is agreeing to sell off portions of their vascular and electrophysiology units, worth about $1.12 billion, to Terumo. The transaction is ...